dr. guru sonpavde, dana-farber cancer institute, usa
Published 5 years ago • 71 plays • Length 2:01Download video MP4
Download video MP3
Similar videos
-
6:57
dr. guru sonpavde
-
1:44
dr. guru sonpavde on bladder cancer | dana-farber cancer institute
-
2:10
highlights in bladder cancer
-
2:02
dana-farber cancer institute: guru sonpavde, md at asco gu21 (bladder cancer)
-
1:49
dana-farber cancer institute: guru sonpavde, md at asco gu21 (urothelial carcinoma)
-
13:59
the medical minute - ep. #15 - psma results
-
7:17
exploring results of the sunlight trial in metastatic colorectal cancer: josep tabernero, md, phd
-
34:38
strategies for nsclc: clinical pathways in the era of biomarker-driven care
-
2:07
dana-farber cancer institute: guru sonpavde, md (bladder cancer research at asco gu21)
-
1:25
bladder cancer research: immunotherapy outcomes | dana-farber cancer institute
-
1:26
dr. sonpavde on remaining questions with immunotherapy in bladder cancer
-
1:17
bladder cancer research: metabolomic plasma profiling | dana-farber cancer institute
-
1:23
bladder cancer research at esmo 2021
-
2:17
how are clinical trials used in prostate cancer? | dana-farber cancer institute
-
0:55
how common is prostate cancer? | dana-farber cancer institute
-
0:46
dr. sonpavde on the need for phase 3 data with pembrolizumab or atezolizumab in bladder cancer
-
1:10
dr. sonpavde on the potential for neoadjuvant immunotherapy in bladder cancer
-
1:47
dr. sonpavde on the safety profile of erdafitinib in bladder cancer
-
3:55
critical trial review in gu oncology, interview with guru sonpavde md
-
1:05
dr. sonpavde on the role of durvalumab in platinum-refractory bladder cancer
-
1:08
dr. sonpavde on ongoing trials with immunotherapy for penile cancer
-
2:11
dr. mary-ellen taplin on treating prostate/gu cancers | dana-farber cancer institute